Health Affairs January 26, 2022
Editor’s Note
This post is part of the Health Affairs Forefront short series, “Value Assessment: Where Do We Go Post-COVID?” The series explores what we have learned about value assessment and related issues during the coronavirus pandemic, how we might think about value in health care going forward, and how these ideas might translate into policy. The series is produced with the support of the Innovation and Value Initiative (IVI) and grew out of a group of webinars hosted jointly by IVI and ISPOR—The Professional Society for Health Economics and Outcomes Research. Included posts are reviewed and edited by Health Affairs Forefront the opinions expressed are those of the authors.
The emergence of SARS-CoV-19 two years ago sparked global upheaval...
Today's Sponsors
Today's Sponsor